Join        Login             Stock Quote

Bioclinica (BIOC) To Go Private At 20 Pct Premium

 January 30, 2013 10:14 AM

(By Balaseshan) BioClinica Inc. (NASDAQ: BIOC) said it has agreed to go private for $7.25 per share, representing a 20% premium to the previous closing price of shares of the provider of clinical research technology solutions.

BioClinica is being bought by a holding company controlled by private equity firm JLL Partners Inc. The holding company will begin a cash tender offer to buy all of BioClinica's common stock at a price of $7.25 a share, which results in an equity value of about $123 million.

Any BioClinica shares not tendered in the offer will be purchased in a second-step merger at the same cash price as paid in the tender offer. BioClinica's board has unanimously approved the definitive merger agreement.

The transaction will be financed by an equity commitment from JLL Partners and Ampersand Capital. The parties expect the tender offer to close before the end of this year's first quarter. Following completion of its proposed acquisition, BioClinica's stock will no longer trade on the NASDAQ stock exchange.

Simultaneously, JLL Partners said it has agreed to acquire CoreLab Partners Inc., a provider of medical imaging solutions and cardiac safety services based in Princeton, New Jersey.

The proposed acquisition of CoreLab Partners is contingent on the closing of the BioClinica transaction. Both acquisitions are expected to close concurrently.

Following the proposed acquisitions, BioClinica and CoreLab Partners will be merged to create a provider of medical imaging services and best-in-class eClinical solutions for clinical trials.

Ampersand Capital Partners, which is the majority owner of CoreLab Partners, will also be a significant investor in the combined company, which will be led by BioClinica's President and CEO Mark Weinstein.

BIOC is trading up 19.54% at $7.22 on Wednesday. The stock has been trading between $4.60 and $7.22 for the past 52 weeks.

iOnTheMarket Premium


Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageChart Says This Retailer's Comeback Isn't Finished

One of the surprises, at least on the surface, of the market's recent swoon was the outperformance of read on...

article imageETF Performance Review: Major Asset Classes | 19 Dec 2014

It’s all about real estate investment trusts (REITs) these days when it comes to bullish performance among read on...

article imageOil and Global Stock Markets Rebounding Sharply

So far so good on our expectation of a 4 to 5% pullback and then a resumption of the bull read on...

article imageGrading the FOMC

Love its members or loathe them, you have to admire the gradual impact the policy-making committee has had read on...

Popular Articles

Daily Sector Scan
Partner Center

Related Articles:

Recent Articles by Balaseshan
More Articles on: Medical

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.